Pacira BioSciences Inc. presented data from three real-world studies supporting the economic value of Exparel (bupivacaine liposome injectable suspension) in total hip arthroplasty (THA) and total knee arthroplasty… read more.
A new study published in Otolaryngology–Head and Neck Surgery, the official peer-reviewed publication of the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF), finds that two common and treatable causes… read more.
Researchers presenting at the American Geriatrics Society (AGS) Virtual Annual Scientific Meeting (#AGS26), taking place April 30th – May 2nd (pre-conference days Monday, April 27th – Wednesday, April 29th), represent the leading… read more.
Vertex Pharmaceuticals Incorporated announced the FDA has approved expanded use of Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a… read more.
Mutations in a key protein make a yeast found in dogs with common outer ear infections more resistant to the topical antifungals used to treat it, veterinarians and… read more.
Direct-acting antivirals (DAAs) can cure hepatitis C (HCV) in more than 95% of individuals treated. But only 1 in 3 people with HCV in the U.S. receive treatment… read more.
The European Medicines Agency (EMA) has approved an update to the product information for Wegovy injection that allows the medicine to stay at a controlled temperature of up… read more.
One in four U.S. adults — the equivalent of over 66 million Americans — report having used artificial intelligence tools or chatbots for physical or mental healthcare information… read more.
Amgen announced positive topline results from a Phase III trial of Tepezza (teprotumumab-trbw) administered by subcutaneous injection via an on-body injector (OBI) in participants with moderate-to-severe active Thyroid… read more.
Lundbeck announced that new data across its neurology portfolio will be presented at the American Academy of Neurology (AAN) Annual Meeting 2026, taking place April 18–22 in Chicago,… read more.
BD (Becton, Dickinson and Company) announced application of CE Mark for the Liverty TIPS Stent Graft, delivering innovation to portal hypertension care across the European Union. Designed to… read more.
Shionogi & Co., Ltd. announced that they have completed the transfer of all rights for Radicava (edaravone), including intellectual property rights and sales rights, in major countries and… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
